Helicobacter pylori Infection and Chronic Immune Thrombocytopenia.
#Neurologist scida greenwood trial#
A randomized controlled trial to compare Helicobacter pylori eradication rates between the empirical concomitant therapy and tailored therapy based on 23S rRNA point mutations. Kim SJ, Jee SR, Park MI, Jung K, Kim GH, Lee MW, Lee J, Jang JS, Koh M Busan and Gyeongnam Society of Helicobacter and Upper Gastrointestinal Research.
#Neurologist scida greenwood update#
Alterations in the gastric microbiota and metabolites in gastric cancer: An update review. Karbalaei M, Keikha M. Statistical proof of Helicobacter pylori eradication in preventing metachronous gastric cancer after endoscopic resection in an East Asian population. Evaluation of a New Monoclonal Chemiluminescent Immunoassay Stool Antigen Test for the Diagnosis of Helicobacter pylori Infection: A Spanish Multicentre Study. Resina E, Donday MG, Martínez-domínguez SJ, Laserna-mendieta EJ, Lanas Á, Lucendo AJ, Sánchez-luengo M, Alcaide N, Fernández-salazar L, De La Peña-negro L, Bujanda L, Arbulo MGD, Alcedo J, Pérez-aísa Á, Rodríguez R, Hermida S, Brenes Y, Nyssen OP, Gisbert JP. Analysis of oral microbiota alterations induced by Helicobacter pylori infection and vonoprazan-amoxicillin dual therapy for Helicobacter pylori eradication. Hu Y, Xu X, Ouyang YB, He C, Li NS, Xie C, Peng C, Zhu ZH, Xie Y, Shu X, Lu NH, Zhu Y. Association of Barrett's esophagus with Helicobacter pylori infection: a meta-analysis. Ma S, Guo X, Wang C, Yin Y, Xu G, Chen H, Qi X.
Current and Future Perspectives in the Diagnosis and Management of Helicobacter pylori Infection. Helicobacter pylori and cardiovascular risk: Only a dead Helicobacter is a good Helicobacter? Helicobacter 2022 :e12928.
Wernly S, Semmler G, Völkerer A, Flamm M, Aigner E, Niederseer D, Wernly B, Datz C. Gastroduodenale Ulkuskrankheit und Helicobacter pylori. pylori eradication treatment with antisecretory drugs. Editorial: slow progress to optimising H. pylori eradication treatment with antisecretory drugs-authors' reply. empirical 10-day quadruple treatment for Helicobacter pylori-infected patients: A prospective clinical trial of first-line therapy. Antibiotic resistance of Helicobacter pylori isolated from patients in Nanjing, China: A cross-section study from 2018 to 2021. Jiang Z, Qian X, Wang Z, Dong Y, Pan Y, Zhang Z, Wang S. Tailored therapy for Helicobacter pylori eradication: A systematic review and meta-analysis. A nationwide cohort study suggests clarithromycin-based therapy for Helicobacter pylori eradication is safe in patients with stable coronary heart disease and subsequent peptic ulcer disease. The influence of gastric atrophy on Helicobacter pylori antibiotics resistance in therapy-naïve patients. Goni E, Tammer I, Schütte K, Thon C, Jechorek D, Mahajan UM, Vasapolli R, Macke L, Aulinger B, Selgrad M, Link A, Malfertheiner P, Schulz C. Management of Helicobacter pylori infection-the Maastricht V/Florence Consensus Report. Malfertheiner P, Megraud F, O'Morain CA, Gisbert JP, Kuipers EJ, Axon AT, Bazzoli F, Gasbarrini A, Atherton J, Graham DY, Hunt R, Moayyedi P, Rokkas T, Rugge M, Selgrad M, Suerbaum S, Sugano K, El-Omar EM European Helicobacter and Microbiota Study Group and Consensus panel.
0 kommentar(er)
